ArticlePhotodermatology, photoimmunology & photomedicine2025
Spectral Transmittance Analysis of Different Sunscreens Used in Daylight Photodynamic Therapy.
Article in Photodermatology, photoimmunology & photomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spectral Transmittance Analysis of Different Sunscreens Used in Daylight Photodynamic Therapy.Photodermatology, photoimmunology & photomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe protocol for daylight photodynamic therapy (DL-PDT) includes the application of sunscreen with an SPF > 30 to block UV radiation and prevent sunburn during the 2 h of exposure to sunlight. Inorganic filters such as titanium dioxide and zinc oxide are not recommended, as they block the visible light needed to activate the photosensitizer. However, some sunscreens containing only organic filters can block 60% of the absorption spectrum of Protoporphyrin IX (PpIX). MATERIALS AND
methodsDifferent sunscreens commonly used to perform DL-PDT in clinical practice were investigated by measuring their spectral transmittance. Skydome irradiances were used to calculate the absorption of PpIX, combined with these sunscreens. To perform a comprehensive analysis of this activation cream in combination with them, five distinct spectral regions were delineated for examination based on specific regions of interest (ROI): R-I (λ < 475 nm), R-II (475 ≤ λ < 525 nm), R-III (525 ≤ λ < 560 nm), R-IV (560 ≤ λ < 610 nm), and R-V (610 nm ≤ λ).
resultsThe results indicate significant variations in the spectral transmittance and PpIX activation efficiency across different sunscreens. In the R-I region, which is critical for PpIX activation, the PpIX activation without sunscreen was highest at 85%, while the addition of sunscreens drastically reduced activation, ranging from 28% to 8%, depending on the sunscreen. In regions from R-II to R-V, the activation levels were consistently low across all sunscreens evaluated. They showed similar values of approximately 5% in R-II, 3% in R-III, 2% in R-IV, and 1% in R-V, slightly lower than the corresponding PpIX alone values of 7%, 4%, 3%, and 1%, respectively.
conclusionThere are significant differences between sunscreens in terms of their absorption in the PpIX absorption spectrum. These differences do not depend on whether or not they contain inorganic filters but depend on the absorption spectrum of the filters contained in their formulation. These results highlight the impact of sunscreen selection on the efficacy of PpIX activation in DL-PDT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.